Trials / Completed
CompletedNCT02996227
Bilateral Transversus Abdominis Plane Block With Exparel Verus Continuous Epidural Analgesia With Bupivacaine
Comparison of Bilateral Transversus Abdominis Plane Block With Exparel Verus Continuous Epidural Analgesia With Bupivacaine: A Randomized, Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 514 (actual)
- Sponsor
- The Cleveland Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of Bilateral Transversus Abdominis Plane Block with Exparel versus Continuous Epidural Analgesia With Bupivacaine
Detailed description
The investigator goal is to compare the analgesic efficacy of TAP blocks with liposomal bupivacaine (Exparel) and continuous epidural blocks in patients who are scheduled for major lower abdominal surgery. To assess whether TAP block with Exparel is noninferior to continuous epidural analgesia on pain management, defined as noninferior for both pain control and total opioid consumption for 72 hours, in patients who had major lower abdominal surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | TAP block | Transversus Abdominis Plane (TAP) blocks will be performed preoperatively. An in-plane ultrasound will be used in TAP block procedure. |
| PROCEDURE | Epidural analgesia | Epidural catheters will be inserted preoperatively. |
| DRUG | EXPAREL | Once the target area is positioned, plain bupivacaine 0.25%, 20ml will be given to open the space and then single dose (10ml) of liposomal bupivacaine (Exparel) mixed with saline (10 ml) will be injected in each side. Total dose of Exparel will be 20 mL. |
| DRUG | Bupivacaine | Once an epidural catheter is successfully positioned, an infusion will be initiated intraoperatively. Bupivacaine standard solution without additives will be prepared for each patient in epidural group. |
Timeline
- Start date
- 2016-12-01
- Primary completion
- 2019-06-01
- Completion
- 2019-10-01
- First posted
- 2016-12-19
- Last updated
- 2024-01-31
- Results posted
- 2024-01-31
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02996227. Inclusion in this directory is not an endorsement.